Literature DB >> 23249567

Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction.

Mehmet A Ozturk1, Olcay Ozveren, Veysel Cinar, Baran Erdik, Basak Oyan.   

Abstract

Takotsubo syndrome (TTS)/cardiomyopathy is a syndrome that mimics acute myocardial infarction in the absence of coronary artery disease and is characterized by acute onset of chest pain, electrocardiographic abnormalities, and reversible left ventricular dysfunction. It is usually induced by emotional and physical stress. Fluorouracil is one of the most frequently used chemotherapy agents and a relatively common adverse reaction of fluorouracil is cardiotoxicity. Herein we describe a patient without a history of cardiovascular disorder who developed severe heart failure during infusion of fluorouracil for metastatic gastric cancer. Remarkably, the patient did not develop TTS during prior chemotherapy regimen, which also included fluorouracil. The patient's findings were consistent with the proposed TTS diagnostic criteria and coronary angiography was normal, without obstructive coronary artery disease. With supportive care, the patient's cardiac functions returned to normal. TTS is not a well known syndrome to clinicians and this condition appears to occur more frequently than previously thought. In addition to the presented case, a review of the clinical features and outcome of 10 reported cases of fluorouracil-induced TTS is presented.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23249567     DOI: 10.1097/MBC.0b013e3283597605

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  9 in total

1.  5-Fluorouracil-induced acute reversible heart failure not explained by coronary spasms, myocarditis or takotsubo: lessons from MRI.

Authors:  Yama Fakhri; Morten Dalsgaard; Dorte Nielsen; Per Lav Madsen
Journal:  BMJ Case Rep       Date:  2016-06-01

Review 2.  A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.

Authors:  Anne Polk; Kirsten Vistisen; Merete Vaage-Nilsen; Dorte L Nielsen
Journal:  BMC Pharmacol Toxicol       Date:  2014-09-04       Impact factor: 2.483

3.  Transient global ventricular dysfunction in an adolescent affected by pancreatic adenocarcinoma.

Authors:  Maria Debora De Pasquale; Angela Mastronuzzi; Luigi De Sio; Annalisa Serra; Chiara Grimaldi; Marcello Chinali; Ugo Giordano
Journal:  BMC Pediatr       Date:  2016-07-19       Impact factor: 2.125

4.  Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature.

Authors:  Matteo Coen; Fabio Rigamonti; Arnaud Roth; Thibaud Koessler
Journal:  BMC Cancer       Date:  2017-06-02       Impact factor: 4.430

5.  FOLFOX Induced Takotsubo Cardiomyopathy Treated with Impella Assist Device.

Authors:  Swethika Sundaravel; Abdulah Alrifai; Mohamad Kabach; Waqas Ghumman
Journal:  Case Rep Cardiol       Date:  2017-03-07

Review 6.  Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.

Authors:  Jun Hua Chong; Arjun K Ghosh
Journal:  Interv Cardiol       Date:  2019-05-21

Review 7.  Takotsubo cardiomyopathy in cancer patients.

Authors:  Aakash Desai; Arish Noor; Saurabh Joshi; Agnes S Kim
Journal:  Cardiooncology       Date:  2019-07-01

Review 8.  Update of Takotsubo cardiomyopathy: Present experience and outlook for the future.

Authors:  Anastasiia V Bairashevskaia; Sofiya Y Belogubova; Mikhail R Kondratiuk; Daria S Rudnova; Susanna S Sologova; Olga I Tereshkina; Esma I Avakyan
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-07

Review 9.  Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.